The Sir David Cooksey Fellowship is focused on bridging two major gaps in healthcare translation. Firstly, to support deep academic research into non-laboratory biomedical research, including technology development, regulation, intellectual property, clinical adoption and biomanufacturing - areas that currently receive limited support from traditional grant-making organisations. Secondly, to sustainably support the training and development of future translational academic and industry leaders, to ensure that the appropriate skills are available to support biomedical innovations globally across the "Valley of Death".
Dr Michelle van Velthoven will be working with Dr David Brindley, Senior Research Fellow in Healthcare Translation, and Dr Glenn Wells, Chief Operating Officer of the Oxford Academic Health Sciences Network (AHSC), who will provide mentorship and support.
It is an honor to be awarded the Sir David Cooksey Fellowship in Healthcare Translation as it gives me an amazing opportunity to work at the interface of academia, health services, and industry. I am excited to contribute to improving the translation of digital health innovations from research ideas and findings into higher quality care and better health outcomes.
- Dr Michelle van Velthoven
In addition, Dr Michelle van Velthoven said: "I am looking forward to be working with Drs David Brindley and Glenn Wells, David’s research group, the Department of Paediatrics and our collaborators."
Dr Michelle van Velthoven obtained her MSc in Health Technology Assessment (HTA) and BSc in Biomedical Sciences from Radboud University Nijmegen in the Netherlands. She pursued her PhD in mobile health at Imperial College London, supervised by Associate Professor Josip Car and Prof Igor Rudan, and the Capital Institute of Paediatrics in Beijing, which validated the use of text messaging for the collection of information relevant to common childhood illnesses in rural China.
After her studies, Dr Michelle van Velthoven worked on technology appraisals as analyst lead for the BMJ Technology Assessment Group commissioned by NICE. Recently, she worked as a Post Doc in digital health at the University of Oxford Nuffield Department of Primary Care Health Sciences where she developed a framework for assessing the clinical risks of health apps.
Dr Michelle van Velthoven continues her roles as an associate and social media editor for the SAGE journal DIGITAL HEALTH, Honorary Research Fellow at Imperial College London. She is also an external researcher at the IMD business school in Lausanne and an advisory board member for the app SPACE, which aims to help people use their smartphone in a healthy and productive way.